Cartesian Therapeutics
RNAC
RNAC
65 hedge funds and large institutions have $178M invested in Cartesian Therapeutics in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+8
Holders Change %
+14.04%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
12
Increased
27
Reduced
15
Closed
4
Calls
$1.44M
Puts
–
Net Calls
+$1.44M
Net Calls Change
+$1.4M
Top Buyers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.16M |
| 2 |
Man Group
London,
United Kingdom
|
+$2.33M |
| 3 |
AG
Artal Group
Luxembourg
|
+$957K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$933K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$905K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$2.33M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$1.24M |
| 3 |
VEA
Virtus ETF Advisers
New York
|
-$439K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$389K |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$301K |
